A shingles shot may do more than prevent rash — it could help shield the aging brain from dementia, according to a landmark study using real-world data from the UK.
A routine vaccine could offer more than protection from varicella-zoster virus — it could help delay or prevent dementia, according to a robust natural experiment conducted by Stanford researchers and published in the journal Nature. In a recent study, a research team at Stanford University reported that the herpes zoster (shingles) vaccine may lower the risk of developing dementia, offering a potential new tool in the fight against cognitive decline.
Link between herpesviruses and dementia
For years, scientists have explored potential links between neurotropic herpesviruses and dementia. Some evidence suggests that infections caused by these viruses may contribute to neurodegeneration. While vaccination is commonly used to prevent infections, emerging research indicates that vaccines, especially live-attenuated ones, can have broader effects on the immune system, sometimes influencing conditions unrelated to the targeted disease.
However, previous studies examining the relationship between vaccines and dementia have struggled with a key challenge — distinguishing correlation from causation. Many have simply compared dementia rates between vaccinated and unvaccinated individuals, but this approach is prone to bias. Furthermore, factors such as personal health awareness, access to healthcare, and even cognitive ability can influence whether someone gets vaccinated, making it difficult to isolate the true effect of the vaccine.
About the study
In the present study, the researchers utilized the vaccine eligibility rules in Wales, United Kingdom (U.K.), to evaluate the impact of the herpes zoster vaccine on dementia risk. In the U.K., the eligibility for the herpes zoster vaccine was determined solely by birth date. Those born on or after September 2, 1933, were eligible to receive the vaccine, while those born just before this date were not.
This provided the researchers with a unique opportunity to study the vaccine’s effect on dementia risk, as individuals born just a few weeks apart are unlikely to differ in any meaningful way in other aspects of life, except for their access to the vaccine. This rare policy feature enabled researchers to apply a regression discontinuity design, simulating a natural experiment that is highly resistant to confounding. The authors also confirmed their findings using a difference-in-differences instrumental variable (DID-IV) approach, further reinforcing the robustness of their causal claims.
By analyzing large-scale electronic health records, the researchers could compare the long-term dementia risk between these two groups while minimizing confounding factors. The findings were corroborated in a secondary analysis of dementia-related deaths across England and Wales, further strengthening the causal inference. The study used regression discontinuity design, a statistical technique for determining causal relationships, and analyzed data from a seven-year follow-up period.
Major findings
The study found that receiving the herpes zoster vaccine was associated with a 3.5 percentage point reduction in dementia diagnoses over seven years, which translates to a 20% relative decrease. This estimate accounts for the fact that not all individuals who were eligible actually received the vaccine. The protective effect was stronger in women, reaching statistical significance, while the findings in men were inconclusive due to wider confidence intervals.
To confirm their findings, the researchers conducted a separate analysis using death certificate data. This secondary analysis supported their initial conclusions, showing that eligibility for the herpes zoster vaccine reduced dementia-related deaths by approximately 5% over nine years.
Beyond dementia, the study also confirmed that the vaccine significantly reduced the occurrence of shingles, consistent with clinical trial data. However, the observed reduction in dementia risk could not be fully explained by a decrease in shingles cases alone, suggesting that other mechanisms might be at play. Notably, the reduction in dementia incidence only became evident more than one year post-vaccination, supporting theories of long-term immune modulation.
The researchers explored several potential explanations for the vaccine’s apparent protective effect. One hypothesis was that the vaccine helps suppress reactivations of the varicella-zoster virus, which causes shingles. Some studies have suggested that such viral reactivations may contribute to neuroinflammation, a key factor in dementia development.
Another potential mechanism suggested a broader immune-modulating effect of the vaccine. Live-attenuated vaccines, like the herpes zoster vaccine, can stimulate the immune system in ways that extend beyond their primary target. This immune boost may help the body combat other infections or neuroinflammatory processes linked to dementia, potentially via mechanisms such as trained immunity or heterologous adaptive immunity. The study also explored how prior influenza vaccination and autoimmune conditions may modify the vaccine’s effect, supporting the hypothesis that broader immune modulation could contribute to dementia protection.
While these findings are compelling, the researchers acknowledged several limitations. One challenge was the potential under-detection of dementia in health records, as not all cases are formally diagnosed. The study also focused on a specific age group, making it difficult to apply the results to younger populations.
Another important consideration was that the study examined only the live-attenuated herpes zoster vaccine. Importantly, the study focused on the live-attenuated vaccine Zostavax, as the recombinant vaccine Shingrix was introduced only after the study period ended. It is unclear whether the newer vaccine would have the same effects on dementia risk.
Implications and conclusions
Dementia remains one of the most pressing public health challenges worldwide, with no cure currently available. If further research confirms that vaccines can reduce the risk of dementia, this could open up new avenues for prevention. If validated in other settings, the shingles vaccine could represent one of the most effective and cost-effective preventive strategies for dementia. Furthermore, given the widespread availability and safety profile of the herpes zoster vaccine, these findings suggest a promising, low-risk intervention that could potentially help millions of people.
While further research is needed to understand the exact mechanisms at play, this study provides compelling evidence that the herpes zoster vaccine may do more than just prevent shingles — it may also help protect the aging brain.
- Eyting, M., Xie, M., Michalik, F. et al. (2025). A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. DOI:10.1038/s41586-025-08800-x https://www.nature.com/articles/s41586-025-08800-x

News
Shingles vaccine cuts dementia risk by 20%, new study shows
A shingles shot may do more than prevent rash — it could help shield the aging brain from dementia, according to a landmark study using real-world data from the UK. A routine vaccine could [...]
AI Predicts Sudden Cardiac Arrest Days Before It Strikes
AI can now predict deadly heart arrhythmias up to two weeks in advance, potentially transforming cardiac care. Artificial intelligence could play a key role in preventing many cases of sudden cardiac death, according to [...]
NanoApps Medical is a Top 20 Feedspot Nanotech Blog
There is an ocean of Nanotechnology news published every day. Feedspot saves us a lot of time and we recommend it. We have been using it since 2018. Feedspot is a freemium online RSS [...]
This Startup Says It Can Clean Your Blood of Microplastics
This is a non-exhaustive list of places microplastics have been found: Mount Everest, the Mariana Trench, Antarctic snow, clouds, plankton, turtles, whales, cattle, birds, tap water, beer, salt, human placentas, semen, breast milk, feces, testicles, [...]
New Blood Test Detects Alzheimer’s and Tracks Its Progression With 92% Accuracy
The new test could help identify which patients are most likely to benefit from new Alzheimer’s drugs. A newly developed blood test for Alzheimer’s disease not only helps confirm the presence of the condition but also [...]
The CDC buried a measles forecast that stressed the need for vaccinations
This story was originally published on ProPublica, a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. ProPublica — Leaders at the Centers for Disease Control and Prevention [...]
Light-Driven Plasmonic Microrobots for Nanoparticle Manipulation
A recent study published in Nature Communications presents a new microrobotic platform designed to improve the precision and versatility of nanoparticle manipulation using light. Led by Jin Qin and colleagues, the research addresses limitations in traditional [...]
Cancer’s “Master Switch” Blocked for Good in Landmark Study
Researchers discovered peptides that permanently block a key cancer protein once thought untreatable, using a new screening method to test their effectiveness inside cells. For the first time, scientists have identified promising drug candidates [...]
AI self-cloning claims: A new frontier or a looming threat?
Chinese scientists claim that some AI models can replicate themselves and protect against shutdown. Has artificial intelligence crossed the so-called red line? Chinese researchers have published two reports on arXiv claiming that some artificial [...]
New Drug Turns Human Blood Into Mosquito-Killing Weapon
Nitisinone, a drug for rare diseases, kills mosquitoes when present in human blood and may become a new tool to fight malaria, offering longer-lasting, environmentally safer effects than ivermectin. Controlling mosquito populations is a [...]
DNA Microscopy Creates 3D Maps of Life From the Inside Out
What if you could take a picture of every gene inside a living organism—not with light, but with DNA itself? Scientists at the University of Chicago have pioneered a revolutionary imaging technique called volumetric DNA microscopy. It builds [...]
Scientists Just Captured the Stunning Process That Shapes Chromosomes
Scientists at EMBL have captured how human chromosomes fold into their signature rod shape during cell division, using a groundbreaking method called LoopTrace. By observing overlapping DNA loops forming in high resolution, they revealed that large [...]
Bird Flu Virus Is Mutating Fast – Scientists Say Our Vaccines May Not Be Enough
H5N1 influenza is evolving rapidly, weakening the effectiveness of existing antibodies and increasing its potential threat to humans. Scientists at UNC Charlotte and MIT used high-performance computational modeling to analyze thousands of viral protein-antibody interactions, revealing [...]
Revolutionary Cancer Vaccine Targets All Solid Tumors
The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer. Cancer treatment vaccines have been in development since 2010, when the first was approved for prostate cancer, followed [...]
Scientists Uncover Hidden Protein Driving Autoimmune Attacks
Scientists have uncovered a critical piece of the puzzle in autoimmune diseases: a protein that helps release immune response molecules. By studying an ultra-rare condition, researchers identified ArfGAP2 as a key player in immune [...]
Mediterranean neutrino observatory sets new limits on quantum gravity
Quantum gravity is the missing link between general relativity and quantum mechanics, the yet-to-be-discovered key to a unified theory capable of explaining both the infinitely large and the infinitely small. The solution to this [...]